, Tracking Stock Market Picks
Enter Symbol:
Rating: MED

Medifast Inc (NYSE: MED) upgraded to Buy by Sidoti

Monday,  Jan 11, 2016  10:25 AM ET by Lynn Gilbert

Sidoti upgraded Medifast Inc (NYSE: MED) to Buy. Previously,
Sidoti rated Medifast Inc (NYSE: MED) to Neutral on 11/30/2015, when the stock price was valued at $30.22.

Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. The Company?s product lines include weight and disease management, meal replacement, and vitamins primarily manufactured in its modern, the United States Food and Drug Administration (FDA) approved facility in Owings Mills, Maryland. The Company?s operations are primarily conducted through five of its wholly owned subsidiaries, Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSF), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. The Company offers a variety of weight and disease management products under the Medifast brand and for select private label customers. It's distribution channels include Medifast Direct, Take Shape for Life, Medifast Weight Control Centers and Medifast Physicians.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy